Development
Core Scientific, Inc.
CORZ
$12.19
$0.262.18%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 55.00% | 90.54% | 100.25% | 97.49% | -818.68% |
| Total Depreciation and Amortization | -55.24% | -62.29% | -58.41% | -51.91% | 237.59% |
| Total Amortization of Deferred Charges | -21.91% | -- | -- | -- | 175.14% |
| Total Other Non-Cash Items | -127.96% | -122.87% | -112.05% | -128.94% | 433.65% |
| Change in Net Operating Assets | 35.80% | 383.71% | -62.42% | 112.35% | 71.62% |
| Cash from Operations | -81.29% | 110.44% | -87.55% | 651.65% | 5.69% |
| Capital Expenditure | 91.70% | 47.45% | 99.87% | 99.43% | -220.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.06% | 71.56% | -103.63% | -- | 101.26% |
| Cash from Investing | 101.69% | 49.34% | 99.65% | 99.31% | 54.76% |
| Total Debt Issued | -- | -- | -- | -- | -76.89% |
| Total Debt Repaid | -10.32% | 71.70% | 78.82% | 96.03% | -14.10% |
| Issuance of Common Stock | -- | -- | -- | -- | 4,782.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -38.88% |
| Cash from Financing | -148.04% | 65.89% | -116.12% | -100.41% | -77.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -60.50% | 87.54% | -75.15% | 180.26% | 151.52% |